Explore the words cloud of the ReproMech project. It provides you a very rough idea of what is the project "ReproMech" about.
The following table provides information about the project.
Coordinator |
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Organization address contact info |
Coordinator Country | Germany [DE] |
Total cost | 162˙806 € |
EC max contribution | 162˙806 € (100%) |
Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
Code Call | H2020-MSCA-IF-2018 |
Funding Scheme | MSCA-IF-EF-ST |
Starting year | 2019 |
Duration (year-month-day) | from 2019-08-01 to 2021-07-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH | DE (NEUHERBERG) | coordinator | 162˙806.00 |
Vertebrate eggs can induce the reprogramming of transplanted somatic nuclei to enable the generation of all cell types of a cloned organism. However, the efficiency of nuclear reprogramming is low, and only a small proportion of the nuclear transfer embryos generated from differentiated cells reach a reproductive adulthood. How the egg achieves the erasure of the previous somatic cell identity and the establishment of totipotency only in some instances remains a question of fundamental importance. Epigenetic modifications were shown to be major roadblocks to reprogramming, but how these roadblocks resist removal by the egg factors and how they are instead propagated during early embryonic cell divisions to induce inappropriate expression of genes in nuclear transfer embryos is not known. This proposal aims at identifying the molecules in the egg that a) help to overcome the epigenetic barriers during successful reprogramming events and b) cause resistance when reprogramming fails. We will then c) interfere with these mechanisms to improve cell fate conversion. The gained molecular insights into cell fate reprogramming via the natural activities present in the egg can then be utilized to develop efficient reprogramming strategies for therapeutic purposes such as enhancing regeneration or improving cell replacement therapies.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REPROMECH" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "REPROMECH" are provided by the European Opendata Portal: CORDIS opendata.